DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
7.01
-0.08 (-1.13%)
At close: Sep 15, 2025, 4:00 PM EDT
7.15
+0.14 (2.00%)
After-hours: Sep 15, 2025, 7:15 PM EDT
DiaMedica Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
28
Market Cap
362.34M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DMAC News
- 10 days ago - DiaMedica Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 13 days ago - DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference - Business Wire
- 4 weeks ago - DiaMedica: Interim Results Brings Study Expansions For DM199 In Preeclampsia - Seeking Alpha
- 4 weeks ago - DiaMedica Therapeutics Inc. (DMAC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - Business Wire
- 5 weeks ago - DiaMedica Therapeutics Appoints Julie Krop, MD, as Chief Medical Officer - Business Wire
- 5 weeks ago - DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025 - Business Wire
- 7 weeks ago - DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement - Business Wire